Abstract

Obesity‐associated type 2 diabetes and accompanying diseases have developed into a leading human health risk across industrialized and developing countries. The complex molecular underpinnings of how lipid overload and lipid metabolites lead to the deregulation of metabolic processes are incompletely understood. We assessed hepatic post‐translational alterations in response to treatment of cells with saturated and unsaturated free fatty acids and the consumption of a high‐fat diet by mice. These data revealed widespread tyrosine phosphorylation changes affecting a large number of enzymes involved in metabolic processes as well as canonical receptor‐mediated signal transduction networks. Targeting two of the most prominently affected molecular features in our data, SRC‐family kinase activity and elevated reactive oxygen species, significantly abrogated the effects of saturated fat exposure in vitro and high‐fat diet in vivo. In summary, we present a comprehensive view of diet‐induced alterations of tyrosine signaling networks, including proteins involved in fundamental metabolic pathways.

Details

Title
High‐fat diet in a mouse insulin‐resistant model induces widespread rewiring of the phosphotyrosine signaling network
Author
Dittmann, Antje 1 ; Kennedy, Norman J 2 ; Soltero, Nina L 3 ; Morshed, Nader 1 ; Mana, Miyeko D 4 ; Yilmaz, Ömer H 5 ; Davis, Roger J 6   VIAFID ORCID Logo  ; White, Forest M 7   VIAFID ORCID Logo 

 The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA 
 Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA 
 The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA 
 The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA 
 The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 
 Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA; Howard Hughes Medical Institute, Worcester, MA, USA 
 The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA 
Section
Articles
Publication year
2019
Publication date
Aug 2019
Publisher
EMBO Press
e-ISSN
17444292
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2281758436
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.